Advertisement
Product › Details
UBS Global Healthcare Conference
Next higher product group | conference, investment / investor / financing / VC | |
Organisation | UBS (Group) | |
Ablynx N.V.. (5/16/17). "Press Release: Ablynx to Present at Upcoming USA Investor Conferences". Ghent.
Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announces that it will participate in the following upcoming investor conferences taking place in New York City, USA:
> UBS Global Healthcare Conference: presentation is scheduled for Wednesday 24 May 2017 at 8.30 a.m. Eastern Standard Time (2.30 p.m. Central European Time), followed by a breakout session and one-on-one meetings with institutional investors
> Jefferies Healthcare Conference: presentation is scheduled for Tuesday 6 June 2017 at 11.30 a.m. Eastern Standard Time (5.30 p.m. Central European Time), followed by a breakout session and one-on-one meetings with institutional investors. The presentation will be webcast live and can be accessed on the day via this link.
> JMP Securities Life Sciences Conference: one-on-one meetings with institutional investors are scheduled for Tuesday 20 June 2017
The presentations will be given by Dr Edwin Moses, CEO of Ablynx and will be available on the Company’s website, under the News & Events section.
About Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease. The Company has collaborations with multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co., Inc., Merck KGaA, Novartis, Novo Nordisk and Taisho Pharmaceuticals. The Company is headquartered in Ghent, Belgium. More information can be found on www.ablynx.com.
For more information, please contact:
Ablynx
Dr Edwin Moses
CEO
t: +32 (0)9 262 00 07
m: +32 (0)473 39 50 68
e: edwin.moses@ablynx.com
Lies Vanneste
Director IR
t: +32 (0)9 262 01 37
m: +32 (0)498 05 35 79
e: lies.vanneste@ablynx.com
@AblynxABLX
Ablynx media/analyst relations:
FTI Consulting
Julia Phillips, Brett Pollard, Mo Noonan
t: +44 20 3727 1000
e: ablynx@fticonsulting.com
Disclaimer
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors’ current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its parent or subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Record changed: 2022-07-21 |
Advertisement
» Show all Events!
UBS Global Healthcare Conference
Past & forthcoming events
- [1] Baader Investment Conference [ ]
- [2] Baird Global Healthcare Conference [ ]
- [3] Bank of America Merrill Lynch Global Healthcare Conference (BAML Global Healthcare Conference) [ ]
- [4] Bankhaus Lampe Deutschlandkonferenz [ ]
- [5] Barclays Gene Editing & Gene Therapy Summit [ ]
- [6] Barclays Global Healthcare Conference [ ]
- [7] Berenberg and Goldmann Sachs German Corporate Conference [ ]
- [8] Berenberg Diagnostics Conference [ 2023-05-11 ]
- [9] Berenberg European Conference [ ]
- [10] Berenberg European Conference USA [ ]
- [11] BIO Investor Forum [ ]
- [12] BIO.NRW Business Angel Congress [ ]
- [13] BioCapital Europe conference [ ]
- [14] BioCentury Annual NewsMakers in the Biotech Industry Conference [ ]
- [15] BioSeed European Equity Investment Event for Early-stage Life Science Companies (OBN) [ 2017-11-14 ]
- [16] Bio€quity Europe (conference) [ ]
- [17] Bryan, Garnier & Co Annual European Healthcare Conference [ ]
- [18] Canaccord Genuity Medical Technologies & Diagnostics Forum [ ]
- [19] Cantor Global Healthcare Conference [ ]
- [20] Chardan’s Annual Genetic Medicines Conference [ 2017-10-10 ]
- [21] Citi Annual BioPharma Conference [ ]
- [22] Citi European Healthcare Conference [ ]
- [23] Citi Healthcare Conference [ ]
- [24] Citi Milan & Swiss Healthcare Days [ ]
- [25] Consilium Strategic Communications Annual Healthcare Conference [ ]
- [26] Cowen and Company Annual Health Care Conference [ ]
- [27] Cowen and Company Annual MedTools Conference [ ]
- [28] Cowen and Company Annual Therapeutics Conference [ ]
- [29] Credit Suisse Annual Healthcare Conference [ ]
- [30] Credit Suisse Antibody Day [ ]
- [31] Credit Suisse Global Healthcare Conference London [ ]
- [32] Credit Suisse Summer Biotech Conference [ ]
- [33] dbAccess Berlin Conference [ ]
- [34] dbAccess Pharmaceutical & Healthcare Corporate Day [ ]
- [35] Degroof Petercam’s Healthcare Seminar [ ]
- [36] Deutsche Bank Annual Health Care Conference [ ]
- [37] Deutsches Eigenkapitalforum (German Equity Forum) [ ]
- [38] DZ Bank Equity Conference [ ]
- [39] Entrepreneurship Summit Berlin [ ]
- [40] European Biotech Investor Day in NYC (by Solebury Trout, Goodwin LLC, Deutsche Bank and Nasdaq) [ 2018-07-19 ]
- [41] European Capital Markets Conference [ ]
- [42] European Large & Midcap Event [ ]
- [43] Evercore ISI HealthCONx Conference [ ]
- [44] FT Global Pharma and Biotech Summit [ ]
- [45] Goetzpartners Healthcare Day [ ]
- [46] Goldman Sachs Annual Biotech Symposium [ ]
- [47] Goldman Sachs Annual Global Healthcare Conference [ ]
- [48] Goldman Sachs European Medtech and Healthcare Conference [ ]
- [49] Goldman Sachs European Small & Mid-Cap Symposium [ ]
- [50] Goldman Sachs Healthcare CEOs Unscripted Conference [ ]
- [51] Guggenheim Securities Annual Boston Healthcare Conference [ ]
- [52] H.C. Wainwright Annual Global Investment Conference [ ]
- [53] H.C. Wainwright BioConnect Conference [ 2021-01-11 ]
- [54] H.C. Wainwright Global Life Sciences Conference [ ]
- [55] HealthTech Innovation Days (HTID) (France Biotech) [ 2019-06-24 ]
- [56] High-Tech Gründerfonds Family Day [ ]
- [57] High-Tech Partnering Days (HTGF) [ ]
- [58] J.P. Morgan Annual Healthcare Conference (JPM Healthcare Conference) [ ]
- [59] J.P. Morgan Annual Napa Conference [ ]
- [60] J.P. Morgan European Healthcare Conference [ ]
- [61] J.P. Morgan London Small/Mid Cap Conference (JP Morgan Cazenove Pan-European Small/Mid Cap Conference) [ ]
- [62] Jefferies Cell and Genetic Medicine Summit [ ]
- [63] Jefferies Global Healthcare Conference [ ]
- [64] Jefferies Immuno-Oncology Cell Therapy Summit (Jefferies IO Cell Therapy Summit) [ ]
- [65] Jefferies London Healthcare Conference [ ]
- [66] JMP Securities Life Sciences Conference [ ]
- [67] Ladenburg Thalmann Healthcare Conference [ ]
- [68] Leerink Partners Annual Emerging Biotech Conference [ ]
- [69] Life Science Investors’ Day (Heidelberg) [ ]
- [70] Metzler MicroCap Day [ ]
- [71] Morgan Stanley Annual Global Healthcare Conference [ ]
- [72] Morgan Stanley Annual Laguna Conference [ ]
- [73] Münchner Kapitalmarkt Konferenz (MKK, Munich Capital Markets Conference) [ ]
- [74] Needham & Co. Annual Healthcare Conference [ ]
- [75] Noble Financial Capital Markets’ Annual Investor Conference (NobleCon) [ ]
- [76] Oddo BHF Forum [ ]
- [77] Oppenheimer & Co. Annual Healthcare Conference [ ]
- [78] Pareto Securities Annual Healthcare Conference [ 2000-01-01 ]
- [79] Piper Jaffray GenomeRx Symposium [ ]
- [80] Piper Sandler Annual Healthcare Conference (formerly Piper Jaffray) [ ]
- [81] RBC Capital Markets Global Healthcare Conference [ ]
- [82] Rodman & Renshaw Annual Global Investment Conference [ ]
- [83] Roth Capital Partners Annual Conference [ ]
- [84] Sachs Annual Biotech in Europe Forum (BEF) [ ]
- [85] Sachs Annual European HealthTech CEO Forum (EHTF) [ 2020-02-18 ]
- [86] Sachs Annual European Life Sciences CEO Forum (ELSF) [ ]
- [87] Sachs Annual European MT&DH Forum [ ]
- [88] Sachs Annual HealthTech Investment Forum (HTIF) [ 2021-10-05 ]
- [89] Stifel Nicolaus Weisel Healthcare Conference [ ]
- [90] SVB Leerink CybeRx Series [ ]
- [91] SVB Leerink Global Healthcare Conference [ ]
- [92] UBS Global Healthcare Conference [ ]
- [93] Van Lanschot Kempen Life Sciences Conference [ ]
- [94] Wedbush PacGrow Healthcare Conference [ ]
- [95] Wells Fargo Securities Healthcare Conference [ ]
- [96] Wells Fargo Securities Therapeutics Insights Conference [ ]
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our free web portals Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top